Catalyst Wire Dossier Catalyst Wire Dossier

MK-1972

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-1972, covering 2016-02-05 to 2016-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003) [Phase 1]

See pricing